Use of bevacizumab (Bev) in real life for first-line (fl) treatment of ovarian cancer (OC). Part1: the ENCOURAGE cohort of 1158 patients (pts) by GINECO
- Resource Type
- Source
- Annals of Oncology. 27:vi308
- Subject
Oncology Gynecology medicine.medical_specialty Bevacizumab business.industry First line Hematology medicine.disease Internal medicine Cohort Medicine In real life business Ovarian cancer medicine.drug - Language
- ISSN
- 0923-7534